These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37345798)

  • 1. Management of Patients With Patent Foramen Ovale and Stroke: A National Survey of Interventional Cardiologists and Vascular Neurologists.
    Khan F; Derbas LA; Messé SR; Kavinsky C; Kasner SE; Favilla CG
    J Am Heart Assoc; 2023 Jul; 12(13):e029451. PubMed ID: 37345798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicians' Approach to Patent Foramen Ovale Closure after Stroke: Comparing Cardiologists and Neurologists.
    Khan F; Fiorilli P; Messé SR; Kasner SE; Derbas LA; Kavinsky CJ; Favilla CG
    J Am Heart Assoc; 2022 Jul; 11(14):e025598. PubMed ID: 35861812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements.
    Elzanaty AM; Patel N; Sabbagh E; Eltahawy EA
    Curr Med Res Opin; 2021 Mar; 37(3):377-384. PubMed ID: 33460329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology.
    Mas JL; Derex L; Guérin P; Guillon B; Habib G; Juliard JM; Marijon E; Massardier E; Meneveau N; Vuillier F
    Arch Cardiovasc Dis; 2019; 112(8-9):532-542. PubMed ID: 31378692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Closure of the patent foramen ovale (PFO) in cryptogenic stroke].
    Diener HC; Knebel F
    Herz; 2019 Jun; 44(4):304-309. PubMed ID: 30941472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
    Wiktor DM; Carroll JD
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
    Khan AR; Bin Abdulhak AA; Sheikh MA; Khan S; Erwin PJ; Tleyjeh I; Khuder S; Eltahawy EA
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1316-23. PubMed ID: 24139929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of patent foramen ovale; findings from a nationwide survey.
    Apostolos A; Drakopoulou M; Trantalis G; Ioakeimidis M; Koroboki E; Tsalamandris S; Aggeli C; Ntaios G; Tsioufis C; Tsivgoulis G; Toutouzas K
    J Stroke Cerebrovasc Dis; 2024 Mar; 33(3):107551. PubMed ID: 38241951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.
    Kasner SE; Thomassen L; Søndergaard L; Rhodes JF; Larsen CC; Jacobson J
    Int J Stroke; 2017 Dec; 12(9):998-1004. PubMed ID: 29090661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.
    Akobeng AK; Abdelgadir I; Boudjemline Y; Hijazi ZM
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):165-173. PubMed ID: 29602258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials.
    Abdelaziz HK; Saad M; Abuomara HZ; Nairooz R; Pothineni NVK; Madmani ME; Roberts DH; Mahmud E
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):176-186. PubMed ID: 29726616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprint of : Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology.
    Mas JL; Derex L; Guérin P; Guillon B; Habib G; Juliard JM; Marijon E; Massardier E; Meneveau N; Vuillier F
    Rev Neurol (Paris); 2020; 176(1-2):53-61. PubMed ID: 31787326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventional closure vs. medical therapy of patent foramen ovale for secondary prevention of stroke: updated meta-analysis.
    Vukadinović D; Schirmer SH; Vukadinović AN; Ukena C; Scheller B; Mahfoud F; Böhm M
    Clin Res Cardiol; 2019 Feb; 108(2):157-166. PubMed ID: 30051178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.
    Saver JL; Carroll JD; Thaler DE; Smalling RW; MacDonald LA; Marks DS; Tirschwell DL;
    N Engl J Med; 2017 Sep; 377(11):1022-1032. PubMed ID: 28902590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
    Li J; Liu J; Liu M; Zhang S; Hao Z; Zhang J; Zhang C
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009938. PubMed ID: 26346232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-center experiences with interventional closure of patent foramen ovale: A medium-term follow-up study comparing two patient groups aged under and over 60 years.
    Nachoski D; Schroeder J; Almalla M; Kubini R; Tchaikovski V; Kosinski C; Becker M; Aljalloud A
    Clin Cardiol; 2021 Mar; 44(3):386-391. PubMed ID: 33595868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
    Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
    N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent Foramen Ovale: Stroke and Device Closure.
    Suradi HS; Hijazi ZM
    Cardiol Clin; 2016 May; 34(2):231-40. PubMed ID: 27150171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.